NCT04357574View on ClinicalTrials.gov

Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19

Enrolling by invitationOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

COVID-19Cancer

Interventions

OTHER

Telehealth

patients have virtual visits with Radiation Oncology providers in lieu of in person clinic visits as a necessary response to COVID-19

Trial Locations (1)

27710

Duke Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

University of California, San Diego

OTHER

lead

Duke University

OTHER

NCT04357574 - Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 | Biotech Hunter | Biotech Hunter